Introduction {#sec1}
============

Adipose precursor cells (APCs) are a subpopulation of lineage (Lin)^−^SCA1^+^ adipose-derived stromal cells competent to undergo adipogenesis in vivo and generate a functional adipose depot after transplantation ([@bib28; @bib13; @bib32]). It is widely anticipated that these cells will have an important role in regenerative medicine ([@bib26]). Furthermore, the recent isolation and characterization of APCs from white adipose tissue (WAT) using cell surface markers ([@bib28]) open new avenues of stem cell and metabolic research. These markers can be used to quantify precursor cells within the adipose depot or to isolate cells for transplant or ex vivo assays ([@bib28; @bib14; @bib32; @bib3]). However, it would be of great utility to manipulate gene expression in APCs in their physiologic in vivo context. Such experiments would require the identification of promoter/enhancer sequences that can direct gene expression specifically to this population. Previously, the promoter regions of several genes expressed in mesenchymal progenitors have been isolated and their activity characterized ([@bib21; @bib29; @bib3]). These regulatory elements, when used to drive expression of Cre recombinase, may be useful for genetic manipulation of APCs.

Here we analyze recombination directed by several Cre lines in stromal populations of WAT and brown adipose tissue (BAT). We find that the most commonly used line to direct adipose-specific expression, *Fabp4-Cre* ([@bib10]), is not active in most WAT APCs. We confirm previous studies that *PdgfRα-Cre* ([@bib29]) is active in most WAT APCs ([@bib3]) and also find activity in most BAT Lin^−^SCA1^+^ cells. However, we also detect activity in other adipose stromal cells. In contrast, a line previously reported to direct expression in uncommitted mesenchymal progenitors ([@bib6]), *Prx1-Cre*, has activity restricted to adipose precursors of the subcutaneous inguinal fat pad, with little recombination in other cell types within the fat pads examined. Together, these data serve as a guide for the use of these tools in the manipulation of gene expression in adipose tissues in vivo.

Results {#sec2}
=======

The stromal compartment of adipose depots includes lymphocytes, macrophages, endothelial cells (ECs), fibroblasts, and APCs and, when isolated from adipocytes, is collectively referred to as the stromal vascular fraction (SVF) ([@bib30]). Using a combination of four markers (CD45, CD11b, CD31, and SCA1), SVF cells can be categorized into five populations ([Figures 1](#fig1){ref-type="fig"}A and 1B), including APCs (CD45^−^CD11b^−^CD31^−^SCA1^+^). In culture, these isolated Lin^−^SCA1^+^ cells are highly responsive to standard adipogenic induction cocktail ([Figure 1](#fig1){ref-type="fig"}C and [Figure S1](#app2){ref-type="sec"}A available online). Although cells from BAT with the APC marker profile differentiate ex vivo ([@bib31]) and express markers of BAT ([@bib32; @bib20]), these cells are less well studied than WAT APCs; therefore, we refer to these as Lin^−^SCA1^+^ cells. Cells not labeled by any of the cell surface markers in our scheme (CD45^−^CD31^−^SCA1^−^, hereafter referred to as SCA1^−^CD31^−^ cells) are heterogeneous in size and morphology ([Figures S1](#app2){ref-type="sec"}B and S1C). In order to thoroughly document expression in all stromal cells, we report the recombination data (as in [Figure S1](#app2){ref-type="sec"}D) but have not further characterized this population.

To test whether transgenic Cre mouse lines are capable of specific targeting APCs in vivo, mice carrying the Cre recombinase-responsive *Enhanced Yellow Fluorescent Protein* (*EYFP*) allele in the *Rosa* locus (*Rosa-EYFP*) ([@bib36]) were crossed to one of three Cre lines. These lines were chosen for their common usage in studies of adipose tissue (*Fabp4-Cre*) ([@bib25; @bib4]) or because of previous reports of activity of these Cre lines in adipose or mesenchymal progenitors (*PdgfRα-Cre*, *Prx1-Cre*) ([@bib6; @bib18; @bib3]). The flow cytometry analysis scheme ([Figure 1](#fig1){ref-type="fig"}A) was applied to the SVF of fat pads from *Cre*;*Rosa-EYFP* double transgenic mice.

Fabp4-Cre {#sec2.1}
---------

The *Fabp4* (also called *aP2*) promoter is a widely used tool to direct adipose-specific gene expression and, when used to direct Cre recombinase, adipose-specific gene deletion ([@bib25; @bib4]). Multiple *Fabp4-Cre* lines have been generated ([@bib2; @bib1; @bib10; @bib37]), but the line described by [@bib10] is most commonly used ([@bib25]). Despite confirmation of *Fabp4-Cre* activity in adipose tissues, prior studies did not quantitatively assess the expression of *Fabp4-Cre* in adipose stromal cells or specifically in APCs in vivo. We analyzed the SVF of subcutaneous inguinal and gonadal WAT (iWAT and gWAT, respectively) and of interscapular BAT from male *Fabp4-Cre*;*Rosa-EYFP* mice by flow cytometry. We found that *Fabp4-Cre* directs low levels of recombination in WAT APCs, ranging from 15% in iWAT to 20% in gWAT ([Figure 2](#fig2){ref-type="fig"}A). However, ∼41% of BAT Lin^−^SCA1^+^ cells are recombined ([Figure 2](#fig2){ref-type="fig"}A). In contrast, EYFP expression is observed in 23%--38% of ECs of BAT and WAT. *Fapb4-Cre* directs modest levels of recombination in SCA1^−^CD31^−^ cells (6%--7% across depots) and macrophages (7%--13% across depots), with very few nonmacrophage white blood cells (CD45^+^CD11b^−^) expressing EYFP ([Figure 2](#fig2){ref-type="fig"}A). Similar results were obtained when female mice were examined ([Figure 2](#fig2){ref-type="fig"}B).

The low levels of recombination observed in iWAT APCs led us to wonder about the properties of those select APCs in which *Fabp4-Cre* is active. First, we evaluated gene expression in iWAT APCs for markers of more committed preadipocytes. Interestingly, cells in which *Fabp4-Cre* is active (EYFP^+^) express higher levels of *Fabp4* and *Pparγ* as compared with EYFP^−^ cells ([Figure S2](#app2){ref-type="sec"}A). These findings are consistent with the EYFP^+^ cells being more differentiated than the EYFP^−^ cells. Next, we considered whether these recombined cells are more adipogenic than nonrecombined cells. EYFP^+^ and EYFP^−^ iWAT APCs were sorted, cultured, and induced to differentiate using standard induction cocktail. Both populations differentiated equally well ([Figure S2](#app2){ref-type="sec"}B), indicating that adipogenic capability, at least ex vivo, does not correlate exclusively with *Fabp4-Cre* activity.

*Fabp4* is expressed at low levels in undifferentiated SVF in culture, but rapidly increases its expression with adipogenesis and is highly expressed in mature adipocytes ([@bib33]). We therefore hypothesized that adipogenic differentiation would increase *Fabp4-Cre*-mediated recombination. Both SVF and bone marrow stromal cell (BMSC) cultures contain preadipocytes and are commonly used as ex vivo models of adipogenesis. We monitored *Fabp4-Cre* recombinase activity in cultured iWAT SVF and BMSCs from *Fabp4-Cre*;*Rosa-EYFP* mice. In undifferentiated cells, ∼20% of SVF and ∼1% of BMSCs expressed EYFP ([Figure 2](#fig2){ref-type="fig"}C, left panels). Strikingly, following adipogenic induction, ∼80% of the SVF-derived adipocytes are EYFP^+^, but far fewer (∼52%) of the BMSC-derived adipocytes appear recombined ([Figure 2](#fig2){ref-type="fig"}C, right panels). Thus, *Fabp4-Cre* labeling of adipose precursors and adipocytes is depot dependent.

To monitor *Fabp4-Cre*-mediated recombination in vivo, adipose tissues were fixed, sectioned, and stained for EYFP and markers of adipocytes (perilipin) or ECs (CD31). Since there is green autofluorescence in adipose tissues, single transgenic controls were processed and stained alongside double transgenic tissues for comparison ([Figure S2](#app2){ref-type="sec"}C). As expected, immunostaining of adipose tissue revealed many EYFP^+^ adipocytes in both WAT and BAT ([Figure 2](#fig2){ref-type="fig"}D), although some adipocytes appear unlabeled ([Figure 2](#fig2){ref-type="fig"}D, arrows). We also observed perilipin^−^ structures clearly labeled with EYFP ([Figure 2](#fig2){ref-type="fig"}D, arrowheads), some of which are ECs ([Figure 2](#fig2){ref-type="fig"}E). Importantly, CD31^+^ structures in muscle are also colabeled with EYFP ([Figure 2](#fig2){ref-type="fig"}E). Consistent with the findings of others ([@bib23; @bib25]), we also detect widespread recombined cells in the liver and intestine ([Figure S2](#app2){ref-type="sec"}D). Together, these results demonstrate that *Fabp4-Cre* is expressed in many but not all adipocytes, is not restricted to the adipose lineage, and is not specific to adipose tissues.

PdgfRα-Cre {#sec2.2}
----------

PdgfRα is expressed in many cells of neuroectodermal or mesenchymal origin, including oligodendrocyte precursors ([@bib27]), neural crest cells ([@bib34]), the developing intestine ([@bib16]), testes ([@bib5]), and heart ([@bib8]) and may also mark bone marrow mesenchymal stem cells ([@bib24]). A mouse in which Cre is directed by *PdgfRα* regulatory elements ([@bib29]) was shown to label WAT APCs when combined with other cell surface markers ([@bib3]). Consistent with these latter findings, our analysis of *PdgfRa-Cre;Rosa-EYFP mice* suggests that Cre is active in nearly all (96%--99%) WAT APCs ([Figure 3](#fig3){ref-type="fig"}A). Additionally, we find that most (89%) BAT Lin^−^SCA1^+^ cells are also recombined ([Figure 3](#fig3){ref-type="fig"}A). Moreover, we observe that *PdgfRα-Cre* activity in iWAT is specific for APCs, as only low levels of recombination (\<11%) are detected in white blood cells and ECs. However, *PdgfRα-Cre* induces recombination in 56% of SCA1^−^CD31^−^ cells in gWAT ([Figure 3](#fig3){ref-type="fig"}A). Thus, while this Cre line effectively targets the vast majority of APCs, it is clearly not exclusive to this cell type across adipose depots. Similar results were obtained when female mice were examined ([Figure 3](#fig3){ref-type="fig"}B). In agreement with previous reports of endogenous PdgfRα expression ([@bib24]) and in contrast to *Fabp4-Cre*, *PdgfRα-Cre* also directs expression to most BMSC preadipocytes, as evidenced by the large fraction of EYFP^+^ adipocytes generated following adipogenic induction ([Figure 3](#fig3){ref-type="fig"}C).

Imaging of histological sections of WAT from *PdgfRα-Cre*;*Rosa-EYFP* animals confirms the flow cytometry results, as a high level of recombination in adipocytes is observed ([Figure 3](#fig3){ref-type="fig"}D). Interestingly, not all brown adipocytes are EYFP^+^, perhaps reflecting the slightly lower recombination in BAT Lin^−^SCA1^+^ cells versus WAT APCs ([Figures 3](#fig3){ref-type="fig"}A and 3D, arrow). We also noted recombination in cells surrounding CD31^+^ ECs ([Figure 3](#fig3){ref-type="fig"}E). This finding is intriguing in light of other reports of adipose progenitor cells associated with blood vessels as part of a perivascular niche ([@bib37]). In contrast to *Fabp4-Cre*, very few EYFP^+^ cells were detected in muscle sections from *PdgfRα-Cre*;*Rosa-EYFP* mice, and most of these are intramuscular adipocytes ([Figure 3](#fig3){ref-type="fig"}F). These studies show that *PdgfRα-Cre* is highly active in, but not limited to, APCs of adipose lineages.

Prx1-Cre {#sec2.3}
--------

*Prx1-Cre* directs expression to the embryonic limb bud mesenchyme, flank mesoderm, and a subset of the cranial mesenchyme ([@bib21]), as well as to uncommitted mesenchymal progenitors of several other tissues ([@bib6]). Therefore, it was expected that recombination would be observed in many SVF cells of all adipose depots. However, in striking contrast to the other Cre lines examined, adipose *Prx1-Cre* activity is mostly restricted to iWAT APCs: we observed recombination in \>82% of APCs in both males and females ([Figures 4](#fig4){ref-type="fig"}A and 4B). Intriguingly, modest recombination is observed in gWAT APCs of female mice (∼18%), as well as in SCA1^−^CD31^−^ cells of either depot (14%--22%) ([Figure 4](#fig4){ref-type="fig"}B), but is absent in males ([Figure 4](#fig4){ref-type="fig"}A). Neither sex displays significant recombination in any BAT SVF cell type ([Figures 4](#fig4){ref-type="fig"}A and 4B). Thus, *Prx1-Cre* has unexpected specificity for APCs, and this is particularly evident in male mice. As expected, examination of cultured iWAT SVF or BMSCs revealed a strikingly high percentage of recombination, both prior to and after adipogenic induction ([Figure 4](#fig4){ref-type="fig"}C), which is consistent with previous data showing recombination in limb bud mesenchyme ([@bib21]).

In sections of iWAT, nearly all perilipin^+^ cells also express EYFP ([Figure 5](#fig5){ref-type="fig"}A, left). Also consistent with the flow cytometry results, there are very few EYFP^+^ cells in BAT or gWAT sections from male mice ([Figure 5](#fig5){ref-type="fig"}A, right). However, in agreement with the Cre activity detected in APCs, there are perilipin^+^EYFP^+^ cells in female gWAT ([Figure 5](#fig5){ref-type="fig"}B). Similar to our results with *PdgfRα-Cre*;*Rosa-EYFP* mice and in contrast to our observations of *Fabp4-Cre;Rosa-EYFP* iWAT, some EYFP^+^ cells in *Prx1-Cre*;*Rosa-EYFP* iWAT surround but do not overlap with CD31^+^ cells ([Figure 5](#fig5){ref-type="fig"}C, upper panel).

Interestingly, staining of muscle tissue reveals recombination in a number of adipocytes, as well as in scattered CD31^−^ cells ([Figure 5](#fig5){ref-type="fig"}C, lower panel). However, EYFP expression is not detectable in the myofibers, suggesting cells expressing the *Prx1-Cre* transgene do not contribute to the muscle lineage, even though muscle progenitors arise from mesenchymal stem cells ([@bib6]). Rare cells showing recombination are also detected in the liver and intestine of *Prx1-Cre;Rosa-EYFP* mice ([Figure S3](#app2){ref-type="sec"}). In summary, our findings suggest that *Prx1-Cre* has a surprisingly restricted expression pattern in adipose and other tissues and a high degree of specificity for APCs in the iWAT.

Discussion {#sec3}
==========

Recent studies have elucidated surface markers that can be used to distinguish and isolate APCs in adipose tissue from other stromal cell populations ([@bib28]). However, continued progress in the field relies on the identification of tools for targeted manipulation of APCs in vivo. In this study, we assessed the ability of different Cre mouse lines to target APCs relative to other adipose stromal populations. While prior studies have examined recombination in selected stromal cells directed by either *Fabp4-Cre* ([@bib33]) or *PdgfRα-Cre* ([@bib3]), here we provide a quantitative report of in vivo Cre recombinase activity in all stromal populations of WAT and BAT depots.

Comparative analysis of the expression patterns directed by the various Cre lines reveals important distinctions. In particular, the most widely used line for directing adipose-specific recombination, *Fabp4-Cre*, is poorly suited to target APCs. A previous study of *Fabp4-Cre;Rosa-TdTomato* mice reported substantially higher numbers of recombined precursors (∼60% in both WAT and BAT) than reported here, using the same cell surface marker profile ([@bib33]). However, Shan and colleagues evaluated cells that were cultured after sorting, whereas in our study, the EYFP reporter expression is quantified in vivo. *Fabp4-Cre* is neither active in the majority of APCs of any depot, nor is it specific for APCs: other stromal cells types, particularly ECs, display similar or even higher levels of recombination ([Figures 2](#fig2){ref-type="fig"}A and 2B). Since *Fabp4* expression increases with adipogenic differentiation, it is plausible that the *Fabp4-Cre* recombination of APCs marks a more committed subset of cells ([@bib20]), although additional studies are required to substantiate this hypothesis.

Despite low levels of recombination in APCs, substantial activity of *Fabp4-Cre* is apparent in mature adipose tissues, consistent with the initial characterization ([@bib10]), and this should contribute to the phenotypes observed in studies that utilize this promoter. However, the lack of fidelity to the adipose lineage is clear, as recombination has been detected in muscle and liver ([Figures 2](#fig2){ref-type="fig"}E and [S2](#app2){ref-type="sec"}D, respectively; [@bib23; @bib25]), embryonic limb bud and dorsal root ganglion ([@bib40]), adrenal medulla and brain ([@bib22]), and other tissues ([@bib25]). These other sites of expression could be a feature of this particular transgenic line, but analysis of another independently generated *Fabp4-Cre* line ([@bib1]) also identified many nonadipose sites of recombination ([@bib19]). Together, these findings suggest that *Fabp4-Cre* is not a suitable tool for effective and specific targeting of APCs.

In contrast to *Fabp4-Cre*, *PdgfRα-Cre* is highly active in both WAT and BAT Lin^−^SCA1^+^ cells, demonstrating the highest recombination efficiency among all examined Cre lines. However, we observed *PdgfRα-Cre* activity in other stromal populations ([Figures 3](#fig3){ref-type="fig"}A--3C). While further evaluation will be required, the expression of Cre in other lineages could confound the results of in vivo experiments utilizing this line to study adipose tissue biology. The *PdgfRα-Cre* line characterized here was generated using a large genomic fragment, from a bacterial artificial chromosome, in an effort to capture the regulatory elements required for the complex endogenous *PdgfRα* expression pattern ([@bib41]). However, it would be highly useful to isolate regulatory elements for particular progenitor populations. Such findings should allow more precise targeting of each cell group and may inform the lineage hierarchy among progenitors.

Surprisingly, we discovered that among adipose depots, *Prx1-Cre* activity is specific for iWAT APCs, particularly in male mice. These results were unexpected, given a prior study that reported widespread recombination in both WAT and BAT, purportedly due to recombination at the progenitor stage ([@bib6]). However, that study utilized a different indicator line, *Rosa-lacZ* ([@bib35]), and did not quantify recombination or determine the identity of the cells in which recombination was detected. Here, we comprehensively examine stromal cells from multiple depots and quantify recombination in vivo in defined cell populations. These findings are consistent with the immunostaining results of adipose tissues: high levels of recombination in iWAT, much less in gWAT, and little to no recombination in BAT. Finally, previous work has shown the same Cre allele can direct different expression patterns depending on the mouse strain background ([@bib11]). The mice utilized in our study were maintained in the C57BL/6 background, whereas the prior study utilized a mixed genetic background ([@bib6]). Therefore, some differences in recombination observed between these studies may be the result of background modifiers of *Prx1-Cre* expression.

Our studies do not address whether this recombination pattern reflects physiological expression of *Prx1*, the activity of isolated *Prx1* promoter elements, or results from chromosomal positional effects of this particular transgenic line. The documented expression of *Prx1-Cre* in the limb bud ([@bib21]) and our own studies of bone marrow cultures ([Figure 4](#fig4){ref-type="fig"}C) suggest that experiments with these mice will require careful interpretation. However, for the study of genes primarily essential to adipose tissue function, our results highlight the utility of *Prx1-Cre* over *PdgfRα-Cre*, as the restricted activity of the former within adipose depots allows for the study of gene function specifically in iWAT APCs. Previous studies in mice have shown that iWAT transplanted into the visceral cavity is metabolically protective, resulting in decreased overall fat mass, improved glucose homeostasis, and insulin sensitivity, although the reasons for these benefits are not well understood ([@bib39]). The specificity of *Prx1-Cre* activity could enable the identification of genes responsible for these and other known functional differences among fat depots, including gene expression, adipokine release, APC proliferation, and lipid homeostasis ([@bib38]). Interestingly, another recently characterized Cre line is active in various visceral adipose depots, including gWAT, but not in iWAT or BAT ([@bib7]), and thus will be a useful complementary tool to analyze alongside *Prx1-Cre*-directed recombination.

Finally, inducible (Cre-ER) versions of these lines have been generated using the same or similar promoter elements ([@bib12; @bib27; @bib17; @bib15]). However, even if the same genomic sequences are used, the unique integration site of each transgenic line and mouse genetic background will likely alter the Cre expression pattern from what is reported here. We would recommend that investigators employing these and other lines evaluate the expression patterns to assess the specific Cre recombination profiles. Nevertheless, it will be worthwhile to examine whether increased temporal resolution can further restrict the Cre activity and thus increase their specificity for defined target populations.

Experimental Procedures {#sec4}
=======================

Mouse Models {#sec4.1}
------------

All studies were approved by Stanford University's Administrative Panel on Laboratory Animal Care Committee. Mouse lines were obtained from JAX Mice: *Fabp4-Cre*, stock \#005069 ([@bib10]); *Prrx1-Cre*, stock \#005584 ([@bib21]); *PdgfRα-Cre*, stock \#013148 ([@bib29]); and *Rosa-EYFP*, stock \#006148 ([@bib36]). Hemizygous male Cre mice for each line were crossed to homozygous female *Rosa-EYFP* indicator mice, and both male and female progeny were analyzed.

Preparation of SVF and BMSC Cultures {#sec4.2}
------------------------------------

Animals were euthanized by asphyxiation with CO~2~ and cervical dislocation, and adipose depots were excised. Tissues were minced and incubated in 1 mg/ml collagenase (Worthington) in Dulbecco's modified Eagle's medium (DMEM)/F12 for 1 hr at 37°C with 5% CO~2~. After inactivation of the digest with an equal volume of DMEM/10% fetal bovine serum (FBS), samples were passed through a 100 μm cell strainer. For cell culture, samples were centrifuged at 300 *g* for 5 min, and the resulting SVF was resuspended in complete media (DMEM/10% FBS/1% penicillin/streptomycin) and plated for imaging or differentiation. For BMSCs, the femurs and tibia were flushed with complete media. The flushed cells were triturated briefly, resuspended in additional complete media, and then cultured for imaging and differentiation. Adipogenic induction was carried out as described ([@bib9]).

Flow Cytometry and Fluorescence-Activated Cell Sorting {#sec4.3}
------------------------------------------------------

Antibodies used include SCA1 Pacific Blue (BioLegend, 108120), CD45 PE-Cy7 (eBioscience, 25-0421-82), CD11b APC-Cy7 (BioLegend, 101226), and CD31 APC (eBioscience, 17-0311-82). SVF was prepared as for cell culture, except that following centrifugation, the resulting cell pellet was resuspended in 1 ml ACK Lysing Buffer (Invitrogen) to remove red blood cells. After inactivation with Hank's balanced salt solution (HBSS)/2% FBS, samples were centrifuged again and resuspended in HBSS/2% FBS for antibody labeling for flow cytometry or fluorescence-activated cell sorting (FACS). Samples were analyzed on a BD LSR Fortessa analyzer or sorted on a BD FACS Aria II. Cell gating was based on comparison with unstained and fluorescence-minus-one-stained controls. Single live cells were discriminated by forward-scatter and side-scatter analysis and 7-AAD labeling (BD Bioscience), respectively. Cells were sorted into serum-free DMEM media for gene expression analysis or into complete media for cell culture. Flow cytometry standard files were analyzed using FlowJo version 10.

Histological Analysis {#sec4.4}
---------------------

Antibodies used include chicken anti-GFP (Aves, GFP-1020), rabbit anti-Perilipin (Sigma, P1998), and rat anti-CD31 (BD Bioscience, 553370). Mice were transcardially perfused with PBS followed by 4% formaldehyde in PBS. Tissues were excised and fixed overnight, cryoprotected in 30% sucrose in PBS, then frozen in OCT (Sakura), and stored at −80°C. Cryosections (10 μm) were prepared using a Leica cryostat and mounted on SuperfrostPlus sides (Fisher). After drying, sections were blocked with 5% bovine serum albumin, followed by labeling with primary antibody for 1 hr at room temperature. After five washes with PBS/0.1% Triton X-100, sections were incubated with appropriate secondary antibodies (goat antichicken Alexa 488, A11039; goat antirat Alexa 647, A21247; goat antirabbit 647, A21244; all from Invitrogen) for 30 min at room temperature. Following additional washes, coverslips were mounted with DAPI antifade reagent (Vector Labs) and sealed with clear nail polish. Images were obtained using inverted Leica epifluorescence microscope, pseudocolored using ImageJ, and merged in Photoshop CS4 (Adobe Creative Suites).
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![Flow Cytometry Schema to Profile Adipose Stromal Cells and Validation by Ex Vivo Differentiation\
(A) Flow cytometry schema of adipose stromal cell types using combinations of cell surface markers, applied to all *Cre*;*Rosa-EYFP* adipose depots.\
(B) Representative flow cytometry plots of inguinal WAT live cells. (Left panel) Plot of live cells stained with CD45 (PE-Cy7) and CD11b (APC-Cy7). (Middle panel) Plot of CD45^−^CD11b^−^ cells stained with SCA1 (Pacific Blue) and CD31 (APC). (Right panel) Histogram of EYFP fluorescence within APCs (Lin^−^SCA1^+^). Label above plots indicates parent populations.\
(C) iWAT APCs cultured in growth media (left) or adipogenic induction media (right), shown 6 days after induction. Scale bar represents 0.5 mm.\
See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![*Fabp4-Cre* Recombinase Activity in Adipose Stromal Populations, Culture, and Tissue Sections\
(A) Flow cytometry profile of *Fabp4-Cre*;*Rosa-EYFP* male mice (n = 3), where each n is one animal. Data are represented as mean ± SEM.\
(B) Flow cytometry profile of *Fabp4-Cre*:*Rosa-EYFP* female mice (n = 3), where each n is one animal. Data are represented as mean ± SEM.\
(C) Expression of EYFP in cultured cells, prior to or after adipogenic induction. The estimated percentage of EYFP^+^ cells or adipocytes is indicated. Scale bar represents 0.2 mm.\
(D) Expression of EYFP and perilipin (red), a marker of adipocytes, in sections of adipose tissue. Arrows indicate nonrecombined adipocytes. Arrowheads indicate putative endothelial structures labeled by EYFP. Scale bar represents 0.1 mm.\
(E) Expression of EYFP and CD31 (red) in sections of adipose tissue or skeletal muscle. Scale bar represents 0.1 mm.\
Mac, macrophage. See also [Figure S2](#app2){ref-type="sec"}.](gr2){#fig2}

![*PdgfRα-Cre* Recombinase Activity in Adipose Stromal Populations and in Tissue Sections\
(A) Flow cytometry profile of *PdgfRα-Cre*;*Rosa-EYFP* male mice (n = 3), where each n is one animal. Data are represented as mean ± SEM.\
(B) Flow cytometry profile of *PdgfRα-Cre*;*Rosa-EYFP* female mice (n = 3), where each n is one animal. Data are represented as mean ± SEM.\
(C) Expression of EYFP in cultured BMSCs, prior to or after adipogenic induction. The estimated percent EYFP^+^ cells or adipocytes is indicated. Scale bar represents 0.2 mm.\
(D) Expression of EYFP and perilipin (red) in sections of WAT and BAT. Arrows indicate nonrecombined adipocytes. Arrowheads indicate putative vascular structures labeled by EYFP. Scale bar represents 0.1 mm.\
(E) Expression of EYFP and CD31 (red) in sections of adipose tissue. Scale bar represents 0.1 mm.\
(F) Expression of EYFP and perilipin (red) in skeletal muscle. Scale bar represents 0.1 mm.\
Mac, macrophage. See also [Figure S3](#app2){ref-type="sec"}.](gr3){#fig3}

![*Prx1-Cre* Recombinase Activity in Adipose Stromal Populations and in Cultured Cells\
(A) Flow cytometry profile of *Prx1-Cre*;*Rosa-EYFP* male mice (n = 3), where each n is one animal.\
(B) Flow cytometry profile of *Prx1-Cre*;*Rosa-EYFP* female mice (n = 3), where each n is one animal. Data are represented as mean ± SEM.\
(C) Expression of EYFP in cultured cells, prior to or after adipogenic induction. The estimated percentage of EYFP^+^ cells or adipocytes is indicated. Scale bar represents 0.2 mm.\
Mac, macrophage.](gr4){#fig4}

![*Prx1-Cre* Recombinase Activity in Tissue Sections\
(A) Expression of EYFP and perilipin (red) in sections of male WAT and BAT. Arrowheads indicate putative ECs labeled by EYFP. Scale bar represents 0.1 mm.\
(B) Expression of EYFP and perilipin (red) in sections of gonadal tissue from male and female mice. Scale bar represents 0.1 mm.\
(C) Expression of EYFP and CD31 (red) in sections of male iWAT and skeletal muscle. Scale bar represents 0.1 mm.\
Mac, macrophage; gWAT, gonadal (epididymal or parametrial for male or female, respectively) WAT. See also [Figure S4](#app2){ref-type="sec"}.](gr5){#fig5}
